// App-Quantinova.ai

1332 : Dual antibody gold nanoconjugate significantly enhances cytotoxicity in metastatic breast cancer

Researchers

Presenter

  • Ajit Zambre

Principal Investigators

  • Anandhi Upendran

  • Matthew Leevy

  • Sarah Chapman

  • Raghuraman Kannan

Medical Centers

  • University of Missouri-Columbia, Columbia, MO

  • University of Notre Dame, Notre Dame, IN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

  • Erb-B2 Receptor Tyrosine Kinase 3

  • Extracellular signal-regulated kinase

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved